Health & Beauty

Home > News > Health & Beauty

Lanzhou New Area builds a northwest pharmaceutical logistics distribution center to undertake the ob

2023-06-06

Building the Chongqing Pharmaceutical Group Gansu Logistics Center in Lanzhou New Area is conducive to the distribution of tertiary medical institutions in various cities, prefectures, and counties in Gansu. It can also undertake the landing of imported drugs from countries along the Belt and Road through Lanzhou in Lanzhou, reduce the transportation cost of imported drugs in the northwest region, and help people in the northwest region better use drugs in a healthy manner, "said Wang Yang, General Manager of Chongqing Pharmaceutical Group (Gansu) Co., Ltd.

From June 2nd to 3rd, the Gansu Logistics Center of Chongqing Pharmaceutical Group settled in Lanzhou New Area, and the first high-quality innovation and development forum for pharmaceutical circulation in Gansu Province was held. National pharmaceutical logistics industry experts conducted comprehensive discussions on hot topics in policies, standards, and other fields, discussing how the pharmaceutical circulation industry can develop high-quality, meet the diverse drug needs of the public, and contribute wisdom to drug quality and safety. Huacheng Import and Export Data Observation Report.

Lanzhou New Area is the first national level new area in the northwest region, an important national industrial base, an important strategic platform for opening up to the west, and a demonstration area for undertaking industrial transfer. It is an important connection point between the Silk Road Economic Belt and the Eurasian "Continental Bridge".

Wang Yang introduced that the center will integrate pharmaceutical logistics resources within Gansu Province, achieve three-level medical institution delivery, meet the medication needs of various medical institutions in Gansu Province, and achieve safe, accurate, and efficient drug delivery throughout the entire process. After completion, it can meet the logistics throughput of 5 billion yuan per year for drugs and equipment.

Gansu is a golden area for the construction of the "the Belt and Road", a national comprehensive experimental area of traditional Chinese medicine industry, and a national biopharmaceutical industry base. The high-quality development of the pharmaceutical industry has obvious advantages and promising prospects. Gansu is known as the "millennium medicine town" and "natural medicine warehouse", with 18 medicinal herbs certified by the National Geographic Indication. The static storage capacity of traditional Chinese medicine in the province remains above 1 million tons, and the annual trading volume of traditional Chinese medicine materials remains above 1.5 million tons.

According to Huacheng Import and Export Data Observation, in 2022, Gansu Province issued the "14th Five Year Plan" for the development of the biopharmaceutical industry, constructing a development pattern of "one core, one circle, and multiple zones", and creating a billion level biopharmaceutical industry chain. Accelerate the investment of 190 million yuan to build the Gansu Biological Products Batch Issuance and Drug Safety Assessment Laboratory, and create a "highland" for biopharmaceutical technology services in the northwest region.

Wang Sheng, Director of the Gansu Provincial Drug Administration, stated that the center's landing in the new area has built a new big platform and fast channel for the circulation of drugs in the province, forming a circulation network radiating across the five provinces and regions in the northwest. The grassroots medical innovation and training platform established by AstraZeneca in cooperation with Heavy Pharmaceutical will provide advanced and sustainable professional services for grassroots medical personnel, improve the accessibility of grassroots medical and health services, and provide practical benefits to grassroots patients.

Wang Sheng said that drug circulation is an important sector. We need to seek opportunities in the overall pattern of "three medical linkage", with the goal of establishing a modern drug distribution system, promoting industry transformation and upgrading as the main line, with the direction of circulation informatization, standardization, and intensification, and with the focus on improving the industry development environment, to create a good development environment and promote high-quality development of the drug distribution industry.

This forum focuses on "high-quality innovative development", which helps to play an important supporting role in serving the medical and health industry in the drug distribution industry. It also helps to improve the service capacity, circulation efficiency, and quality safety of drug supply and security, deepen the "three medical linkage", and promote the "social co governance" of drug safety. It is of great significance for promoting the inheritance and development of pharmaceutical culture and jointly safeguarding human health.

Wang Sheng also suggested innovating development methods and business models, guiding drug retail chain enterprises to focus on the core goal of "health management", actively improving the level of "pharmaceutical services", promoting the construction of digital and intelligent pharmacies, and promoting "online and offline integration" to promote "three medical linkage". Exploring the establishment of pharmaceutical service and health management demonstration pharmacies to promote industry innovation and development, Huacheng Import and Export Data Observation Report.

Zhongyao Group is a leading enterprise in the digital transformation of business in China's pharmaceutical distribution industry, serving the entire pharmaceutical industry chain, while also engaged in pharmaceutical research and development, medical device production, and investment in the pharmaceutical industry. Yuan Quan, Secretary of the Party Committee and Chairman of the company, stated that the heavy pharmaceutical logistics project in Gansu is also the most modern pharmaceutical logistics center in the northwest region. Huacheng Import and Export Data Observation Report.

Yuan Quan believes that building a modern pharmaceutical logistics center here is necessary to support the development of Gansu's pharmaceutical and health industry; It is the integration of third-party pharmaceutical logistics resources in Gansu Province, the realization of distribution by grassroots medical institutions, and the satisfaction of the needs of the public to use drugs and make good use of them; It is also to undertake the landing of imported drugs from countries along the "the Belt and Road" in Lanzhou, which will become the distribution center of Gansu, Ningxia, Qinghai and even the west. Huacheng Import and Export Data Observation Report.


DISCLAIMER: All information provided by HMEonline is for reference only. None of these views represents the position of HMEonline, and HMEonline makes no guarantee or commitment to it. If you find any works that infringe your intellectual property rights in the article, please contact us and we will modify or delete them in time.
© 2022 Company, Inc. All rights reserved.
WhatsApp